SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-067431
Filing Date
2017-12-27
Accepted
2017-12-27 17:15:16
Documents
1
Period of Report
2017-12-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1521
  Complete submission text file 0001209191-17-067431.txt   3236
Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Issuer) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CALITHERA BIOSCIENCES 343 OYSTER POINT BLVD, SUITE 200 SO. SAN FRANCISCO CA 94080
Business Address
Waddill William D. (Reporting) CIK: 0001553338 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38042 | Film No.: 171276632